Search results
Results From The WOW.Com Content Network
Pervasive refusal syndrome (PRS), also known as pervasive arousal withdrawal syndrome (PAWS) is a rare hypothesized pediatric mental disorder. [1] [2] [3] PRS is not included in the standard psychiatric classification systems; that is, PRS is not a recognized mental disorder in the World Health Organization's current and upcoming International Classification of Diseases and the current ...
Post-acute withdrawal syndrome (PAWS) is a hypothesized set of persistent impairments that occur after withdrawal from alcohol, [1] [2] opiates, benzodiazepines, antidepressants, and other substances. [3] [4] [5] Infants born to mothers who used substances of dependence during pregnancy may also experience a PAWS.
Treatment often involves promoting better communication and socializing, and reducing behaviors that can be disruptive. Children with pervasive developmental disorders may be placed in special education classes, receive behavior modification training, speech, physical or occupational therapy, or medication.
Resignation syndrome (also called traumatic withdrawal syndrome or traumatic refusal or abandonment syndrome; Swedish: uppgivenhetssyndrom) is a condition that induces a state of reduced consciousness, not recognized by the World Health Organization as a valid psychiatric condition. It was first described in Sweden in the 1990s.
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
Enjoy a classic game of Hearts and watch out for the Queen of Spades!
Persistent Müllerian duct syndrome; Pervasive refusal syndrome; Peters-plus syndrome; Peutz–Jeghers syndrome; Pfeiffer syndrome; Phantom eye syndrome; Phantom limb; Phantom vibration syndrome; Phelan-McDermid Syndrome; Pickwickian syndrome; Pigment dispersion syndrome; Pigmented hairy epidermal nevus syndrome; Pilotto syndrome; Piriformis ...
White explained in an email that his reaction to Hazelden’s plan was “one of pleasant surprise that a leading addiction treatment program would so value the emerging addiction science and be so committed to improving recovery outcomes that it would be willing to weather potential controversy that could affect its business interests.”